Abstract:The link between tumors and the hemostatic system, first of all platelets, has been acknowledged by numerous studies. Platelets activation at the tumor microenvironment and subsequent intravascular clotting are often associated with cancer complications. Recent clinical studies demonstrated that platelet inhibitors substantially decrease risk of tumor metastasis and mortality in cancer patients, thereby emphasizing clinical importance of platelets. However, the precise function of platelets in cancer progression remains enigmatic. Growing tumors secrete a plethora of growth factors and cytokines (tumor secretome) aiming to change its micro- and macro-environment. These factors promote angiogenesis, induce inflammation, and even stimulate changes in bones prior to metastasis. Tumor secretome signals are likely transmitted through the circulation; however, these signals need to be protected from degradation or utilization prior to reaching their target. Due to their ability to intake and secrete back a wide spectrum of proteins, platelets could function as a mobile storage compartment for the tumor secretome. Using platelet infusion and depletion during tumor growth, we assessed the role of platelets in tumor growth and tumor-induced bone remodeling. We demonstrated that platelet infusion stimulates communications between bone marrow and the tumor, while platelet depletion had the opposite effects. Importantly, tumor-induced changes in bone structure were completely abolished in the absence of platelets. Using platelets from knockout mice with various platelet defects, we demonstrated that platelet secretion (but not aggregation) was crucial for their function in tumor progression. In particular, the function of platelet α-granules is essential for the pro-tumorigenic role of platelets. Analysis of the tumor secretome revealed that 77 percent of tumor-secreted factors are highly enriched within platelets over plasma. Several of these factors are essential mediators of bone remodeling. Thus, our data show that platelet α-granule sequestration and secretion represent a cellular mechanism mediating communication between the bone microenvironment and the primary tumor.

Mechanisms of platelet activation in cancer-associated thrombosis: a focus on myeloproliferative neoplasms

Novel Pathophysiological Mechanisms of Thrombosis in Myeloproliferative Neoplasms

Platelets and cancer: a casual or causal relationship: revisited

Platelet-Leukocyte Interplay in Cancer Development and Progression

Thrombosis and hemorrhage in myeloproliferative neoplasms: The platelet perspective

Thrombosis in Philadelphia negative classical myeloproliferative neoplasms: a narrative review on epidemiology, risk assessment, and pathophysiologic mechanisms

Platelets and the Tumor Cell Microenvironment

Role of Platelet Activation in the Development and Metastasis of Solid Tumors

Emerging roles of platelets in cancer biology and their potential as therapeutic targets

Lessons to learn from tumor-educated platelets

A role for platelets in metabolic reprogramming of tumor-associated macrophages

Platelets and circulating (tumor) cells: partners in promoting metastatic cancer

Role of platelets and platelet receptors in cancer metastasis

Interactions of platelets with circulating tumor cells contribute to cancer metastasis

Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin

Platelets in the Tumor Microenvironment and Their Biological Effects on Cancer Hallmarks

Inhibition of Platelet Function: Does It Offer a Chance of Better Cancer Progression Control?

The dynamic role of platelets in cancer progression and their therapeutic implications

Platelets and extracellular vesicles and their cross talk with cancer

The critical role of platelet in cancer progression and metastasis